HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Sept. 25, 2015 (HealthDay News) -- Management of genetic conditions during pregnancy may require a multidisciplinary approach, according to a Committee Opinion from the American College of Obstetrics and Gynecology (ACOG) published in the October issue of Obstetrics & Gynecology.
Noting that advances in understanding of genetic conditions, reproductive technologies, and improved medical and surgical care is allowing an increased number of women to achieve normal pregnancy outcome, researchers from the ACOG Committee on Genetics discuss the management of genetic conditions during pregnancy.
The authors note that management of certain genetic conditions is complex and may necessitate a multidisciplinary approach from before conception through the postpartum period. A preconception evaluation with obstetrician-gynecologists, genetics specialists, maternal-fetal medicine specialists, or other appropriate subspecialists is recommended in order to optimize care for patients with certain genetic conditions, or those at risk of having a particular genetic condition. Preimplantation genetic testing with in vitro fertilization should be offered to patients with established causative mutations for a genetic condition and who desire prenatal genetic testing. Once pregnant, patients should undergo initial examination early in the first trimester to allow for coordination of prenatal screening or testing and assessment of pregnancy risks.
"In treating women with genetic conditions during pregnancy, we must consider not just the health of the woman and her ability to carry and deliver a baby safely," Joseph R. Biggio Jr., M.D., chair of the College's Committee on Genetics, said in a statement. "Ob-gyns must also consider that women with these rare medical conditions may rely on medications that might have a teratogenic effect on the fetus, leading to potential complications during infancy and childhood and even into adulthood. However, in some cases, it may be medically necessary to continue medication."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022